On the contrary, the activation of NLRP3 could also lead to inflammatory tissue injury, including intestinal and systemic inflammatory diseases and hepatic veno-occlusive disease [51, 52]. This evidence concerns the gene NLRP3 and hepatic veno-occlusive disease.